Medical Advisory Board

Dr. Girish N. Vyas

Emeritus Professor of Lab Medicine, UCSF, Founder, First Academic Transfusion Medicine Research Program

Dr. Girish N. Vyas received his Ph.D. from the University of Bombay and his F.R.C. Path in Virology, Immunology, and Transfusion Medicine from the University of London; in addition, he completed a postdoctoral fellowship at Case-Western University. He served as a professor in the Department of Laboratory Medicine at UCSF School of Medicine and Director of Blood Bank at UCSF Medical Center. He has made seminal contributions to our current knowledge about IgA deficiency and anaphylactic transfusion reactions, HBsAg structure, HBV vaccine and immune globulins in perinatal prevention of mother to child transmission of infection. He has advanced screening and elimination of transfusion-transmitted HBV, HCV, HIV to enhance transfusion safety, and sustained commitment to immune prevention of HIV/AIDS. These contributions earned him the honor of a "Pioneer and Pathfinder in Transfusion Medicine" in 2008. In addition, he has received numerous other honors and awards. He has edited 12 books and monographs and published 225 original papers. He has served on several committees of NAS-NRC, NIH, CDC, FDA, WHO, AABB, ASH, and UNDP and as the Editor-in-Chief of Biologicals. Currently, he is an Emeritus Professor of Laboratory Medicine at UCSF and full-time CEO of TheraBiol, Inc., a start-up biotech company launched in 2012 for R&D of antibodies for prevention and treatment of persistent infections. 

Dr. Laurence J. Marton

Former Dean of University of Wisconsin Medical School; Medical Director, RenovoRx

Dr. Marton received his M.D. from the Albert Einstein College of Medicine and his B.A. from Yeshiva University. He served as Dean of the University of Wisconsin Medical School and chaired the Department of Laboratory Medicine at UCSF, where he was a Professor in the Departments of Laboratory Medicine and Neurological Surgery. He has received numerous honors and awards. Currently, he serves as a consultant to industry and to nonprofit, government, and academic institutions. In the nonprofit sector, Dr. Marton serves on the Board of Trustees of the American Association for Cancer Research Foundation, and on the Board of Directors of Cancer Commons, Rapid Science, and the Bay Area American Committee for the Weizmann Institute of Science. In the for-profit sector, he is on the Board of Directors of Cellsonics, Dategra, Matternet, Microsonic Systems, Pathologica, RenovoRx, TOMA Biosciences, and xCures; is Chair of the Scientific Advisory Board of PharmaJet; is an advisor to Citizen and the Precision Medicine World Conference; and is on the Editorial Board of the Journal of Precision Medicine.

Dr. Fred Naider

Distinguished Professor of Biochemistry and Chemistry, The College of Staten island and the Graduate Center of the City University of New York. Former Provost and Senior Vice President for Academic Affairs at the College of Staten Island

 

Dr. Naider received his PhD in Polymer Chemistry from the Polytechnic Institute of Brooklyn after receiving a B.S. and M.S. in Chemical Engineering from Cornell University. He then did two years of Postdoctoral training at the Weizmann Institute of Science in Rehovot, Israel. His research career has spanned a period of 50 years and the focus of his work is on the biology and biochemistry of peptides and proteins. His research was supported by grants from the National Institutes of Health for over 35 years. His work has led to fundamental insights into how peptides enter cells and how proteins interact with one another to generate signals that regulate all aspects of physiology and homeostasis. Recent work has involved the interactions of the gp120 protein of the HIV-1 virus and chemokines with a co-receptor found in lymphocytes and macrophages. Previously he was involved in structural biology projects as the basis for a rational approach to develop a vaccine against HIV-1. He has been an advisor to biotech and pharmaceutical companies and worked with several Israeli startups.

Dr. Naider is a fellow of the American Association for the Advancement of Science and has published nearly 300 articles and chapters in peer reviewed journals and books.

Dr. Yosef Levenbrown

Critical Care Medicine; Medical Director, Clinical Apheresis Services, DuPont Hospital 

Dr. Yosef Levenbrown received his medical degree from the University of Medicine and Dentistry of New Jersey and completed fellowship training in Pediatric Critical Care Medicine at Alfred I. duPont Hospital for Children. Currently, he serves as an attending physician in the division of Pediatric Critical Care Medicine at Alfred I. duPont Hospital for Children, Clinical Assistant Professor of Pediatrics at Sidney Kimmel Medical College - Thomas Jefferson University and Medical Director of Clinical Apheresis Services at Alfred I. duPont Hospital for Children. He has authored numerous publications in the field.

Dr. Chava Ruderman

Internal Medicine; Public Health 

Dr. Chava (Emma) Ruderman is a graduate of the Albert Einstein College of Medicine, and completed a residency in internal medicine with a focus on primary care at Jacobi Medical Center of NYC Health + Hospitals. She holds a master’s degree in public health with a concentration in epidemiology and biostatistics from the City University of New York, and is currently completing a second residency in public health and preventive medicine. She has experience in survey design, program evaluation, data analysis, and disease outbreak investigations, and has particular interests in the social determinants of health, trauma-informed care, and systems change in primary care.

© 2020 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.